Evidence map›Paper›PMID 31975834›Full record

ReviewFocus (American Psychiatric Publishing)2017

Overview of Neurocognitive Disorders.

William M McDonald

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Focus (American Psychiatric Publishing), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Diagnosis and Management of Major Neurocognitive Disorder: A Simulation-Based Curriculum.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Review
  17. Tobacco cigarette smoking induces cerebrovascular dysfunction followed by oxidative neuronal injury with the onset of cognitive impairment.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025
    Article
  18. Review
  19. The effect of azelaic acid on AlClActa neuropsychiatrica · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

William M McDonaldDr. McDonald is with the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA (e-mail: wmcdona@emory.edu).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive function is a major determinant of an individual's quality of life. However, the number of individuals developing a neurocognitive disorder (NCD) is increasing as the population ages: the number of individuals with dementia is doubling every 20 years and will reach over 115 million worldwide by 2050. There is a need to identify vulnerable individuals early, understand the trajectory of their NCD, and intervene with effective treatments. The

Indexed as

Cognitive DisordersDementiaDiagnosis and Classification in NeuropsychiatryGeriatric NeuropsychiatryNeuropsychiatry/neurobiology

Identifiers

PMID31975834
PMCPMC6519631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.